Diagnosis and management of Addison's disease: Insights gained from a large South African cohort

Journal of Endocrinology, Metabolism and Diabetes of South Africa

Volumn 16, Issue 2, 2011, Pages 86-92

  Ross, Ian L ^a   Levitt, N S ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Addison's disease; Aetiology; Complications; Management

Indexed keywords

CORTISONE ACETATE; DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; MINERALOCORTICOID; PREDNISONE;

ADDISON DISEASE; ADRENAL INSUFFICIENCY; AUTOIMMUNITY; CARDIOVASCULAR RISK; CLINICAL FEATURE; COHORT ANALYSIS; HORMONE SUBSTITUTION; HUMAN; HYPERPIGMENTATION; MASS SPECTROMETRY; PREVALENCE; REVIEW; SCREENING; SOUTH AFRICA; STRESS;

EID: 84865082957     PISSN: 16089677     EISSN: None     Source Type: Journal    
DOI: 10.1080/22201009.2011.10872256     Document Type: Review

References (72)

1. Arlt W, Allolio B. Adrenal insufficiency. Lancet 2003;361(9372):1881- 1893.
2. Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, Johannsson G. Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab. 2006;91(12):4849-4853.
3. Erichsen MM, Lovas K, Fougner KJ, et al. Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. Eur J Endocrinol. 2009;160(2):233-237.
4. Lovas K, Husebye ES. High prevalence and increasing incidence of Addison's disease in western Norway. Clin Endocrinol (Oxf). 2002;56(6):787-791.
5. Ten S, New M, Maclaren N. Clinical review 130: Addison's disease 2001. J Clin Endocrinol Metab. 2001;86(7):2909-2922.
6. Erichsen MM, Lovas K, Skinningsrud B, et al. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab. 2009;94(12):4882-4890.
7. Ross I, Boulle A, Soule S, et al. Autoimmunity predominates in a large South African cohort with Addison's disease of mainly European descent despite long-standing disease and is associated with HLA DQB&z.ast;0201. Clin Endocrinol (Oxf). 2010;73(3):291-298.
8. Nieman LK, Chanco Turner ML. Addison's disease. Clin Dermatol. 2006;24(4):276-280.
9. Potti A, Schell DA. Unusual presentations of thoracic tumors: case 1. Acute adrenal insufficiency due to metastatic lung cancer. J Clin Oncol. 2001;19(17):3780-3782.
10. Cooper H, Bhattacharya B, Verma V, et al. Liquorice and soy sauce, a life-saving concoction in a patient with Addison's disease. Ann Clin Biochem. 2007;44(Pt 4):397-399.
11. Sunkel S, Wichmann-Hesse A, Gartner R, Hesse G. Increasing pigmentation in Schmidt syndrome (polyglandular autoimmune syndrome type II) [Article in German]. Hautarzt 2001;52(10 Pt 2):974-976.
12. DiBartolomeo JR. The petrified auricle: comments on ossification, calcification and exostoses of the external ear. Laryngoscope 1985;95(5):566-576.
13. Lin HH, Yen TH, Huang CC, et al. Blood eosinophilia, corticoadrenal insufficiency and eosinophilic cystitis. Urol Int. 2008;80(2):219-221.
14. Likhari T, Magzoub S, Griffiths MJ, et al. Screening for Addison's disease in patients with type 1 diabetes mellitus and recurrent hypoglycaemia. Postgrad Med J. 2007;83(980):420-421.
15. Christiansen JJ, Djurhuus CB, Gravholt CH, et al. Effects of cortisol on carbohydrate, lipid, and protein metabolism: studies of acute cortisol withdrawal in adrenocortical failure. J Clin Endocrinol Metab. 2007;92(9):3553-3559.
16. Soule S. Addison's disease in Africa - a teaching hospital experience. Clin Endocrinol (Oxf). 1999;50(1):115-120.
17. Felig P, Baxter JD, Frohman LA, editors. Endocrinology and metabolism. 3rd ed. Los Angeles: McGraw-Hill; 1995.
18. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev. 2002;23(3):327-364.
19. Nieman LK. Dynamic evaluation of adrenal hypofunction. J Endocrinol Invest. 2003;26(7 Suppl):74-82.
20. Chakera AJ, Vaidya B. Addison's disease in adults: diagnosis and management. Am J Med. 2010;123(5):409-413.
21. Kazlauskaite R, Evans AT, Villabona CV, et al. Corticotropin tests for hypothalamic-pituitary-adrenal insufficiency: a meta-analysis. J Clin Endocrinol Metab. 2008;93(11):4245-4253.
22. Oelkers W, Diederich S, Bähr V. Diagnosis and therapy surveillance of Addison's disease rapid adrenocorticotrophin (ACTH) test and measurement of plasma ACTH, renin activity and aldosterone. J Clin Endocrinol Metab. 1992;75(1):259-264.
23. Giordano R, Balbo M, Picu A, et al. Corticotrope hypersecretion coupled with cortisol hypo-responsiveness to stimuli is present in patients with autoimmune endocrine diseases: evidence for subclinical primary hypoadrenalism? Eur J Endocrinol. 2006;155(3):421-428.
24. Betterle C, Pra CD, Pedini B, et al. Assessment of adrenocortical function and autoantibodies in a baby born to a mother with autoimmune polyglandular syndrome type 2. J Endocrinol Invest. 2004;27(7):618-621.
25. Betterle C, Coco G, Zanchetta R. Adrenal cortex autoantibodies in subjects with normal adrenal function. Best Pract Res Clin Endocrinol Metab. 2005;19(1):85-99.
26. Falorni A, Laureti S, De Bellis A, et al. Italian Addison's network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency. J Clin Endocrinol Metab. 2004;89(4):1598-1604.
27. Haroche J, Amoura Z, Wechsler B, et al. Erdheim-Chester disease [Article in French]. Presse Med. 2007;36(11 Pt 2):1663-1668.
28. Chedid MF, Chedid AD, Geyer GR, et al. Histoplasmosis presenting as Addisonian crisis in an immunocompetent host. Rev Soc Bras Med Trop. 2004;37(1):60-62.
29. Grover SB, Midha N, Gupta M, et al. Imaging spectrum in disseminated histoplasmosis: case report and brief review. Australas Radiol. 2005;49(2):175-178.
30. Paolo WF, Jr., Nosanchuk JD. Adrenal infections. Int J Infect Dis. 2006;10(5):343-353.
31. Freda PU, Wardlaw SL, Brudney K, Goland RS. Primary adrenal insufficiency in patients with the acquired immunodeficiency syndrome: a report of five cases. J Clin Endocrinol Metab. 1994;79(6):1540-1545.
32. Cusano AJ, Thies HL, Siegal FP, et al. Hyponatremia in patients with acquired immune deficiency syndrome. J Acquir Immune Defic Syndr. 1990;3(10):949-953.
33. Cheung TW, Teich SA. Cytomegalovirus infection in patients with HIV infection. Mt Sinai J Med. 1999;66(2):113-124.
34. Lam KY, Lo CY. Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital. Clin Endocrinol (Oxf). 2002;56(1):95-101.
35. Addison T. On the constitutional and local effects of disease of the suprarenal capsules. London: Samuel Highley; 1855.
36. Cedermark BJ, Sjoberg HE. The clinical significance of metastases to the adrenal glands. Surg Gynecol Obstet. 1981;152(5):607-610.
37. Crispell KR, Parson W, Hamlin J, Hollifield G. Addison's disease associated with histoplasmosis: report of four cases and review of the literature. Am J Med. 1956;20(1):23-29.
38. Ross IL, Marais S, Raubenheimer P, et al. Overt hypoadrenalism is uncommon in patients with stage 3 and 4 bronchogenic carcinoma. S Afr Med J. 2003;93(9):695-699.
39. Redman BG, Pazdur R, Zingas AP, Loredo R. Prospective evaluation of adrenal insufficiency in patients with adrenal metastasis. Cancer 1987;60(1):103-107.
40. Shimozawa N. Molecular and clinical aspects of peroxisomal diseases. J Inherit Metab Dis. 2007;30(2):193-197.
41. Van Geel BM, Assies J, Wanders RJ, Barth PG. X-linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy. J Neurol Neurosurg Psychiatry. 1997;63(1):4-14.
42. Rizzo WB. Lorenzo's oil - hope and disappointment. N Engl J Med. 1993;329(11):801-802.
43. Moser HW. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 1997;120(Pt 8):1485-1508.
44. Berger J, Gartner J. X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects. Biochim Biophys Acta. 2006;1763(12):1721-1732.
45. Aubourg P. On the front of X-linked adrenoleukodystrophy. Neurochem Res. 1999;24(4):515-520.
46. Watkins PA, Chen WW, Harris CJ, et al. Peroxisomal bifunctional enzyme deficiency. J Clin Invest. 1989;83(3):771-777.
47. Spurek M, Taylor-Gjevre R, Van Uum S, Khandwala HM. Adrenomyeloneuropathy as a cause of primary adrenal insufficiency and spastic paraparesis. CMAJ. 2004;171(9):1073-1077.
48. Watson JP, Lewis RA. Schmidt's syndrome associated with sarcoidosis. Postgrad Med J. 1996;72(849):435-436.
49. Handschug K, Sperling S, Yoon SJ, et al. Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum Mol Genet. 2001;10(3):283-290.
50. Satta MA, Corsello SM, Della CS, et al. Adrenal insufficiency as the first clinical manifestation of the primary antiphospholipid antibody syndrome. Clin Endocrinol (Oxf). 2000;52(1):123-126.
51. Schuchmann JA, Friedman PA. Bilateral adrenal hemorrhage: an unusual complication after bilateral total knee arthroplasty. Am J Phys Med Rehabil. 2005;84(11):899-903.
52. Hardy K, Mead B, Gill G. Adrenal apoplexy after coronary artery bypass surgery leading to Addisonian crisis. J R Soc Med. 1992;85(9):577-578.
53. Nawata H, Yanase T, Oba K, et al. Human Ad4BP/SF-1 and its related nuclear receptor. J Steroid Biochem Mol Biol. 1999;69(1-6):323-328.
54. Habiby RL, Boepple P, Nachtigall L, et al. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalmic and pituitary defects in gonadotropin production. J Clin Invest. 1996;98(4):1055-1062.
55. Skinningsrud B, Husebye ES, Gilfillan GD, et al. X-linked congenital adrenal hypoplasia with hypogonadotropic hypogonadism caused by an inversion disrupting a conserved noncoding element upstream of the NR0B1 (DAX1) gene. J Clin Endocrinol Metab. 2009;94(10):4086-4093.
56. MICROMEDEX® Healthcare Series. Vol. 148 [expires 2011 Jun]. Available from: Thomson Reuters, New York.
57. Esteban NV, Loughlin T, Yergey AL, et al. Daily cortisol production in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab. 1991;72(1):39-45.
58. Lovas K, Husebye ES. Replacement therapy in Addison's disease. Expert Opin Pharmacother. 2003;4(12):2145-2149.
59. Li Voon Chong JS, Sen J, et al. Hydrocortisone replacement dosage influences intraocular pressure in patients with primary and secondary hypocortisolism. Clin Endocrinol (Oxf). 2001;54(2):267-271.
60. Chikada N, Imaki T, Hotta M, et al. An assessment of bone mineral density in patients with Addison's disease and isolated ACTH deficiency treated with glucocorticoid. Endocr J. 2004;51(3):355-360.
61. Braatvedt GD, Joyce M, Evans M, et al. Bone mineral density in patients with treated Addison's disease. Osteoporos Int. 1999;10(6):435-440.
62. Van Raalte DH, Ouwens DM, Diamant M. Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur J Clin Invest. 2009;39(2):81-93.
63. Bleicken B, Hahner S, Loeffler M, et al. Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens. Eur J Endocrinol. 2008;159(6):811-817.
64. Meikle AW, Tyler FH. Potency and duration of glucocorticoids. Am J Med. 1977;63(2):200-207.
65. Groves RW, Toms GC, Houghton BJ, Monson JP. Corticosteroid replacement therapy: twice or thrice daily? J R Soc Med. 1988;81(9):514-516.
66. Lennernas H, Skrtic S, Johannsson G. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors. Expert Opin Drug Metab Toxicol. 2008;4(6):749-758.
67. Dekker MJ, Koper JW, Van Aken MO, et al. Salivary cortisol is related to atherosclerosis of carotid arteries. J Clin Endocrinol Metab. 2008;93(10):3741-3747.
68. Monson JP. The assessment of glucocorticoid replacement therapy. Clin Endocrinol (Oxf). 1997;46(3): 269-270.
69. Lovas K, Thorsen TE, Husebye ES. Saliva cortisol measurement: simple and reliable assessment of glucocorticoid replacement therapy in Addison's disease. J Endocrinol Invest. 2006;29(8):727-731.
70. Arlt W, Rosenthal C, Hahner S, Allolio B. Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed cortisol measurements. Clin Endocrinol (Oxf). 2006;64(4):384-389.
71. Debono M, Ghobadi C, Rostami-Hodjegan A, et al. Modified-release hydrocortisone to provide circadian cortisol profiles. J Clin Endocrinol Metab. 2009;94(5):1548-1554.
72. Yong SL, Marik P, Esposito M, Coulthard P. Supplemental perioperative steroids for surgical patients with adrenal insufficiency. Cochrane Database Syst Rev. 2009;7(4):CD005367.